Showing results (2141-2150 of 6,951) with videos related to
Sort By:
Pageof 696
Cancer Science|July 7, 2019
Uridine-cytidine kinase 2 (UCK2): A potential diagnostic and prognostic biomarker for lung cancerYingjie Wu, Muhammad Jamal, Tian Xie, et al.Cancer Science|June 26, 2019
Early clinical outcomes of helical tomotherapy/intensity-modulated proton therapy combination in nasopharynx cancerSeung Gyu Park, Yong Chan Ahn, Dongryul Oh, et al.Cancer Science|October 9, 2019
Experimental identification of cancer driver alterations in the era of pan-cancer genomicsMichael Korenjak, Jiri ZavadilCancer Science|October 11, 2019
Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancerRebecca Kalikawe, Yoshifumi Baba, Daichi Nomoto, et al.Cancer Science|February 24, 2022
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancerYoon Ming Chin, Tomoko Shibayama, Hiu Ting Chan, et al.Cancer Science|January 31, 2022
Long-term effectiveness of HPV vaccination against HPV infection in young Japanese women: Real-world dataMegumi Kurosawa, Masayuki Sekine, Manako Yamaguchi, et al.Cancer Science|February 8, 2022
Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancer: Comment by Mackman et alNigel Mackman, Yohei Hisada, Sierra J ArchibaldCancer Science|February 18, 2022
E2F1-mediated AUF1 upregulation promotes HCC development and enhances drug resistance via stabilization of AKR1B10Ting Zhang, Guiwen Guan, Jing Zhang, et al.Cancer Science|November 2, 2021
Loss of GSTO2 contributes to cell growth and mitochondria function via the p38 signaling in lung squamous cell carcinomaRyusuke Sumiya, Masayoshi Terayama, Teruki Hagiwara, et al.Cancer Science|November 2, 2021
CPI-203 improves the efficacy of anti-PD-1 therapy by inhibiting the induced PD-L1 overexpression in liver cancerXiaoge Niu, Wei Wang, Taizhen Liang, et al.Pageof 696